CA2004991A1 - Analogue de deletion de peptides de magainin - Google Patents

Analogue de deletion de peptides de magainin

Info

Publication number
CA2004991A1
CA2004991A1 CA2004991A CA2004991A CA2004991A1 CA 2004991 A1 CA2004991 A1 CA 2004991A1 CA 2004991 A CA2004991 A CA 2004991A CA 2004991 A CA2004991 A CA 2004991A CA 2004991 A1 CA2004991 A1 CA 2004991A1
Authority
CA
Canada
Prior art keywords
amino acid
magainin
deletion
magainin peptides
carboxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA2004991A
Other languages
English (en)
Other versions
CA2004991C (fr
Inventor
Julio H. Cuervo
Richard A. Houghten
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Scripps Research Institute
Original Assignee
Scripps Clinic and Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scripps Clinic and Research Foundation filed Critical Scripps Clinic and Research Foundation
Publication of CA2004991A1 publication Critical patent/CA2004991A1/fr
Application granted granted Critical
Publication of CA2004991C publication Critical patent/CA2004991C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
CA002004991A 1988-12-09 1989-12-08 Analogue de deletion de peptides de magainin Expired - Fee Related CA2004991C (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/281,981 US4962277A (en) 1988-12-09 1988-12-09 Deletion analogues of magainin peptides
US281,981 1988-12-09

Publications (2)

Publication Number Publication Date
CA2004991A1 true CA2004991A1 (fr) 1990-06-09
CA2004991C CA2004991C (fr) 1999-12-07

Family

ID=23079584

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002004991A Expired - Fee Related CA2004991C (fr) 1988-12-09 1989-12-08 Analogue de deletion de peptides de magainin

Country Status (9)

Country Link
US (1) US4962277A (fr)
EP (1) EP0451190B1 (fr)
JP (1) JP2927539B2 (fr)
KR (1) KR0149015B1 (fr)
AT (1) ATE121755T1 (fr)
CA (1) CA2004991C (fr)
DE (1) DE68922405T2 (fr)
ES (1) ES2071815T3 (fr)
WO (1) WO1990006129A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114634553A (zh) * 2022-04-27 2022-06-17 贵州医科大学 阳离子肽c9及其应用

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5643876A (en) * 1987-03-04 1997-07-01 The United States Of America As Represented By The Department Of Health And Human Services Biologically active synthetic magainin peptides
SE469132B (sv) * 1989-06-16 1993-05-17 Kabigen Ab Polypeptider och farmaceutisk komposition innehaallande denna
US5912231A (en) * 1989-07-07 1999-06-15 Scripps Clinic And Research Foundation Substitution analogues of magainin peptides
US5045531A (en) * 1989-12-18 1991-09-03 Magainin Sciences Inc. Wound treatment employing biologically active ion channel forming peptides and proteins
US5585353A (en) * 1990-02-02 1996-12-17 The Rockefeller University Antibiotic peptides containing D-amino acids
US5792831A (en) * 1990-02-08 1998-08-11 Magainin Pharmaceuticals Inc. Analogues of magainin peptides containing D-amino acids
US5459237A (en) * 1990-02-08 1995-10-17 Magainin Pharmaceuticals Inc. Peptide compositions and uses therefor
US5221664A (en) * 1990-04-23 1993-06-22 Magainin Pharmaaceuticals Inc. Composition and treatment with biologically active peptides and toxic cations
US5208220A (en) * 1990-06-27 1993-05-04 Magainin Pharmaceuticals, Inc. Composition and treatment with biologically active peptides and antibiotics which inhibit DNA gyrase
ATE308562T1 (de) * 1990-08-10 2005-11-15 Virtual Drug Dev Inc Antimikrobielle peptide wirksam gegen pflanzenpathogene, ihre verwendung und auf sie bezogene nachweismethoden
US5235038A (en) * 1991-01-22 1993-08-10 Torry Pines Institute For Molecular Studies Deletion and substitution analogues of melittin peptide
CA2107674A1 (fr) * 1991-04-08 1992-10-09 W. Lee Maloy Nouvelles compositions peptidiques et leur utilisation
US5225399A (en) * 1991-04-15 1993-07-06 The Children's Hospital Of Philadelphia Antimicrobial amphiphilic peptides
US5239059A (en) * 1991-05-10 1993-08-24 The Children's Hospital Of Philadelphia Ion-channel forming peptides
WO1993001723A1 (fr) * 1991-07-25 1993-02-04 Magainin Pharmaceuticals, Inc. Propylaxie et traitement d'affections bucco-dentaires a l'aide de peptides biologiquement actifs
US5885965A (en) * 1991-11-01 1999-03-23 Periodontix, Inc. Anti-fungal D-amino acid histatin-based peptides
WO1994005313A1 (fr) * 1992-08-31 1994-03-17 Magainin Pharmaceuticals Inc. Traitement de tumeurs malignes gynecologiques au moyen de peptides biologiquement actifs
US5424290A (en) * 1992-10-26 1995-06-13 Magainin Pharmaceuticals Inc. Biologically active peptides and uses therefor
WO1994012206A1 (fr) * 1992-12-03 1994-06-09 Magainin Pharmaceuticals, Inc. Traitement de tumeurs dermatologiques malignes avec des peptides bioactifs
US5847047A (en) * 1993-06-22 1998-12-08 E. I. Du Pont De Nemours And Company Antimicrobial composition of a polymer and a peptide forming amphiphilic helices of the magainin-type
JP4076026B2 (ja) * 1993-10-25 2008-04-16 トランセイヴ，インコーポレイテッド リポソームディフェンシン
US6010861A (en) * 1994-08-03 2000-01-04 Dgi Biotechnologies, Llc Target specific screens and their use for discovering small organic molecular pharmacophores
US5688489A (en) * 1995-09-15 1997-11-18 Resolution Pharmaceuticals, Inc. Non-receptor mediated imaging agents

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4810777A (en) * 1987-03-04 1989-03-07 The United States Of America As Represented By The Department Of Health And Human Services Antimicrobial compounds

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114634553A (zh) * 2022-04-27 2022-06-17 贵州医科大学 阳离子肽c9及其应用
CN114634553B (zh) * 2022-04-27 2024-03-08 贵州医科大学 阳离子肽c9及其应用

Also Published As

Publication number Publication date
EP0451190A4 (en) 1992-05-20
KR910700062A (ko) 1991-03-13
EP0451190B1 (fr) 1995-04-26
JP2927539B2 (ja) 1999-07-28
JPH04502159A (ja) 1992-04-16
WO1990006129A1 (fr) 1990-06-14
DE68922405T2 (de) 1996-01-04
DE68922405D1 (de) 1995-06-01
ES2071815T3 (es) 1995-07-01
US4962277A (en) 1990-10-09
EP0451190A1 (fr) 1991-10-16
ATE121755T1 (de) 1995-05-15
CA2004991C (fr) 1999-12-07
KR0149015B1 (ko) 1998-10-15

Similar Documents

Publication Publication Date Title
CA2004991A1 (fr) Analogue de deletion de peptides de magainin
ATE266043T1 (de) Peptidanaloge des menschlichen basischen myelinproteins
AU589176B2 (en) New tetrapyrrole therapeutic agents
ATE177757T1 (de) Verbesserte immunogene zusammensetzung gegen mensliches gastrin 17
SE8605189L (sv) Nya kalcitoninderivat
MX9703642A (es) Metodos para el tratamiento de esclerosis multiple utilizando analogos de peptido en la posicion 91 de la proteina basica de mielina humana.
ES2095255T3 (es) Analogos de sustitucion de peptidos magainina.
ES2012720A6 (es) Procedimiento para la obtencion de sales de adicion de acido de taurina o glicina amidada.
AU525695B2 (en) Pharmaceutical formulations of prostacyclin
AU585167B2 (en) Novel substrate peptides
EP0968721A3 (fr) Utilisation d'une composition peptidique pour l'inhibition du HIV
ES2058290T3 (es) Analogos de somatostatina terapeuticos.
FI901773A0 (fi) Vasoaktiva peptider.
AU5971990A (en) Renin-inhibiting amino oligohydroxy derivatives
DE3471938D1 (en) Antibiotics, method for their preparation, their use as medicines and intermediates for their preparation
ATE87939T1 (de) Glycosylierte aminosaeuren und peptide.
AU2169088A (en) Thionophosphonates
IT1241459B (it) Composizioni farmaceutiche per la somministrazione rettale di calcitonina
JPS53132539A (en) Protected amino acid or peptide having said protected amino acid residue
JPS5791965A (en) Preparation of polypeptide
ATE137741T1 (de) Aminosäurederivate zur peptidsynthese
AU2900989A (en) Peptide analogues of insulin-like growth factor 1 (igf-1) or factor 2 (igf-2)

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed